{"id":350609,"date":"2025-08-25T19:52:21","date_gmt":"2025-08-25T19:52:21","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ascendis-pharma-as\/"},"modified":"2025-08-25T19:52:21","modified_gmt":"2025-08-25T19:52:21","slug":"how-to-buy-ascendis-pharma-as","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Ascendis Pharma A\/S (ASND)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Ascendis Pharma A\/S (ASND)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, \u0111\u00e1nh gi\u00e1 r\u1ee7i ro v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng 2025-2030."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c khai th\u00e1c ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111ang b\u00f9ng n\u1ed5? Ascendis Pharma A\/S (ASND) \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u00e2u chuy\u1ec7n t\u0103ng tr\u01b0\u1edfng h\u1ea5p d\u1eabn nh\u1ea5t trong \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p. V\u1edbi n\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 \u0111\u1ed9t ph\u00e1 TransCon v\u00e0 t\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5, c\u00f4ng ty \u0111\u1ed5i m\u1edbi \u0111\u1ebfn t\u1eeb \u0110an M\u1ea1ch n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o \u00f4ng l\u1edbn d\u01b0\u1ee3c ph\u1ea9m n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c khai th\u00e1c ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111ang b\u00f9ng n\u1ed5? Ascendis Pharma A\/S (ASND) \u0111\u1ea1i di\u1ec7n cho m\u1ed9t trong nh\u1eefng c\u00e2u chuy\u1ec7n t\u0103ng tr\u01b0\u1edfng h\u1ea5p d\u1eabn nh\u1ea5t trong \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p. V\u1edbi n\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 \u0111\u1ed9t ph\u00e1 TransCon v\u00e0 t\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5, c\u00f4ng ty \u0111\u1ed5i m\u1edbi \u0111\u1ebfn t\u1eeb \u0110an M\u1ea1ch n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn l\u1ee3i nhu\u1eadn \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o \u00f4ng l\u1edbn d\u01b0\u1ee3c ph\u1ea9m n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Ascendis Pharma: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Ascendis Pharma A\/S (ASND) giao d\u1ecbch \u1edf m\u1ee9c <strong>194,30 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>13 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. Nh\u01b0ng b\u01b0\u1edbc ngo\u1eb7t th\u1ef1c s\u1ef1 \u0111\u1ebfn ngay tr\u01b0\u1edbc \u0111\u00f3...<\/p> <p><strong>30 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y FDA PDUFA cho ph\u00ea duy\u1ec7t TransCon CNP. Quy\u1ebft \u0111\u1ecbnh duy nh\u1ea5t n\u00e0y c\u00f3 th\u1ec3 l\u00e0m thay \u0111\u1ed5i ho\u00e0n to\u00e0n qu\u1ef9 \u0111\u1ea1o c\u1ed5 phi\u1ebfu trong n\u0103m t\u1edbi. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u1ec1 s\u1ea3n ph\u1ea9m Ascendis \u0111\u00e3 t\u1ea1o ra nh\u1eefng bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn.<\/p> <h3>C\u00e1ch C\u00e1c Quy\u1ebft \u0110\u1ecbnh FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu ASND<\/h3> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>Th\u00e1ng 8\/2024<\/td><td>Ph\u00ea duy\u1ec7t YORVIPATH<\/td><td>145 USD<\/td><td>+28% (1 tu\u1ea7n)<\/td><\/tr> <tr><td>Th\u00e1ng 3\/2025<\/td><td>M\u1edf r\u1ed9ng SKYTROFA<\/td><td>168 USD<\/td><td>+15% (3 ng\u00e0y)<\/td><\/tr> <tr><td>Th\u00e1ng 1\/2025<\/td><td>K\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td><td>132 USD<\/td><td>-12% (d\u1eef li\u1ec7u g\u00e2y th\u1ea5t v\u1ecdng)<\/td><\/tr> <\/tbody> <\/table> <p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: tin t\u00edch c\u1ef1c t\u1eeb c\u01a1 quan qu\u1ea3n l\u00fd th\u00fac \u0111\u1ea9y t\u0103ng tr\u01b0\u1edfng hai ch\u1eef s\u1ed1, trong khi th\u1ea5t b\u1ea1i g\u00e2y ra \u0111i\u1ec1u ch\u1ec9nh \u0111\u00e1ng k\u1ec3. Quy\u1ebft \u0111\u1ecbnh th\u00e1ng 11 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn nh\u1ea5t c\u1ee7a n\u0103m 2025.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 n\u0103m 2025)<\/h3> <p>C\u1ed5 phi\u1ebfu ASND \u0111\u00e3 t\u0103ng \u1ea5n t\u01b0\u1ee3ng <strong>75%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y:<\/p> <ul> <li><strong>Th\u00e1ng 2<\/strong>: 111,09 USD (\u0111\u00e1y 52 tu\u1ea7n, th\u1ecb tr\u01b0\u1eddng kh\u00f4ng ch\u1eafc ch\u1eafn)<\/li> <li><strong>Th\u00e1ng 4<\/strong>: 150,12 USD (v\u01b0\u1ee3t qua trung b\u00ecnh \u0111\u1ed9ng 200 ng\u00e0y)<\/li> <li><strong>Th\u00e1ng 6<\/strong>: 188,79 USD (ti\u1ebfn g\u1ea7n m\u1ee9c cao k\u1ef7 l\u1ee5c)<\/li> <li><strong>Th\u00e1ng 8<\/strong>: 194,30 USD (\u0111i\u1ec1u ch\u1ec9nh g\u1ea7n m\u1ee9c \u0111\u1ec9nh)<\/li> <\/ul> <p>T\u1ea1i sao t\u0103ng m\u1ea1nh nh\u01b0 v\u1eady? Ba t\u1eeb: <strong>t\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5<\/strong>. K\u1ebft qu\u1ea3 qu\u00fd 2 n\u0103m 2025 c\u1ee7a c\u00f4ng ty cho th\u1ea5y doanh thu t\u0103ng v\u1ecdt <strong>339%<\/strong> l\u00ean 158 tri\u1ec7u euro, nh\u1edd c\u00e1c s\u1ea3n ph\u1ea9m YORVIPATH v\u00e0 SKYTROFA ra m\u1eaft th\u00e0nh c\u00f4ng.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <ul> <li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 220-240 USD (ch\u1edd ph\u00ea duy\u1ec7t FDA) \u2192 <strong>MUA M\u1ea0NH<\/strong> n\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li> <li><strong>2026<\/strong>: 260-300 USD (th\u01b0\u01a1ng m\u1ea1i h\u00f3a \u0111\u1ea7y \u0111\u1ee7 TransCon CNP)<\/li> <li><strong>2028<\/strong>: 380-450 USD (m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf)<\/li> <li><strong>2030<\/strong>: 550-650 USD (d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng b\u1ec7nh n\u1ed9i ti\u1ebft hi\u1ebfm g\u1eb7p)<\/li> <\/ul> <p>K\u1ebft lu\u1eadn? \u0110\u00e2y l\u00e0 c\u01a1 h\u1ed9i <strong>r\u1ee7i ro cao, l\u1ee3i nhu\u1eadn cao<\/strong> ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu \u0111\u01b0\u1ee3c bi\u1ebfn \u0111\u1ed9ng ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. Quy\u1ebft \u0111\u1ecbnh FDA th\u00e1ng 11 l\u00e0 t\u1ea5t c\u1ea3\u2014ph\u00ea duy\u1ec7t c\u00f3 th\u1ec3 \u0111\u01b0a c\u1ed5 phi\u1ebfu n\u00e0y l\u00ean t\u1ea7m cao m\u1edbi.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>R\u1ee7i ro b\u1ecb FDA t\u1eeb ch\u1ed1i<\/strong>: gi\u1ea3m 20-30% n\u1ebfu TransCon CNP kh\u00f4ng \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li> <li><strong>Thua l\u1ed7 t\u00e0i ch\u00ednh<\/strong>: l\u1ed7 r\u00f2ng 38,9 tri\u1ec7u euro m\u1eb7c d\u00f9 doanh thu t\u0103ng m\u1ea1nh<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng cao<\/strong>: bi\u1ebfn \u0111\u1ed9ng h\u00e0ng n\u0103m 40,1% g\u00e2y dao \u0111\u1ed9ng gi\u00e1 m\u1ea1nh<\/li> <li><strong>\u00c1p l\u1ef1c c\u1ea1nh tranh<\/strong>: Pfizer v\u00e0 Novo Nordisk \u0111ang nh\u1eafm v\u00e0o th\u1ecb tr\u01b0\u1eddng c\u1ee7a h\u1ecd<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Doanh thu b\u00f9ng n\u1ed5<\/strong>: t\u0103ng tr\u01b0\u1edfng 339% kh\u00f4ng ph\u1ea3i nh\u1ea7m l\u1eabn\u2014\u0111\u00f3 l\u00e0 th\u1ef1c t\u1ebf<\/li> <li><strong>M\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/strong>: YORVIPATH hi\u1ec7n c\u00f3 m\u1eb7t t\u1ea1i h\u01a1n 75 qu\u1ed1c gia tr\u00ean to\u00e0n c\u1ea7u<\/li> <li><strong>D\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t<\/strong>: 494 tri\u1ec7u euro cho ho\u1ea1t \u0111\u1ed9ng<\/li> <li><strong>\u0110\u00e1nh gi\u00e1 c\u1ee7a chuy\u00ean gia<\/strong>: 16 tr\u00ean 16 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 Mua ho\u1eb7c Mua M\u1ea1nh<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>Ch\u1edd \u0111\u1ebfn th\u00e1ng 11<\/strong>: Quy\u1ebft \u0111\u1ecbnh FDA qu\u00e1 quan tr\u1ecdng\u2014\u0111\u1eb7t v\u1ecb th\u1ebf sau tin t\u1ee9c<\/li> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 v\u1edbi t\u1ef7 l\u1ec7 2-3% danh m\u1ee5c<\/li> <li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: t\u1ea1i 175 USD (h\u1ed7 tr\u1ee3 30 ng\u00e0y) v\u00e0 150 USD (trung b\u00ecnh \u0111\u1ed9ng 200 ng\u00e0y)<\/li> <li><strong>Theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/strong>: B\u00e1o c\u00e1o qu\u00fd 3 ng\u00e0y 13 th\u00e1ng 11 s\u1ebd cho th\u1ea5y ti\u1ebfn tri\u1ec3n th\u01b0\u01a1ng m\u1ea1i<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch ASND gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014r\u1ea5t \u0111\u00e1ng gi\u00e1 nh\u01b0ng d\u1ec5 c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng t\u00e2m tr\u1ea1ng m\u1ea1nh m\u1ebd. H\u00e3y chu\u1ea9n b\u1ecb s\u1ef1 \u1ed5n \u0111\u1ecbnh c\u1ea3m x\u00fac v\u00e0 d\u1ea1 d\u00e0y v\u1eefng ch\u1eafc!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ascendis Pharma A\/S (ASND) - T\u1eebng B\u01b0\u1edbc<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng c\u00f3 th\u1ec3 m\u1ea5t<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"ASND\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap tr\u00e1nh tr\u1ea3 gi\u00e1 qu\u00e1 cao khi bi\u1ebfn \u0111\u1ed9ng<\/td><\/tr> <tr><td>5<\/td><td>Th\u1ef1c hi\u1ec7n mua<\/td><td>Xem x\u00e9t ph\u00ed\u2014nh\u1eafm d\u01b0\u1edbi 1% t\u1ed5ng hoa h\u1ed3ng<\/td><\/tr> <\/tbody> <\/table> <h3>T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h3> <p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p> <ul> <li><strong>Ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u 5 USD<\/strong>\u2014th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi ti\u1ec1n th\u1eadt m\u00e0 kh\u00f4ng t\u1ed1n nhi\u1ec1u<\/li> <li><strong>X\u00e1c minh trong 1 ph\u00fat<\/strong>\u2014t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng linh ho\u1ea1t<\/li> <li><strong>C\u1ed5 phi\u1ebfu l\u1ebb<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 ASND<\/li> <\/ul> <h2>\ud83c\udf0d Ascendis Pharma N\u0103m 2025: Cu\u1ed9c C\u00e1ch M\u1ea1ng TransCon<\/h2> <p>Ascendis Pharma kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc b\u00ecnh th\u01b0\u1eddng\u2014h\u1ecd ti\u00ean phong cho t\u01b0\u01a1ng lai \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh n\u1ed9i ti\u1ebft hi\u1ebfm g\u1eb7p. N\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 TransCon c\u1ee7a h\u1ecd l\u00e0 m\u1ed9t b\u01b0\u1edbc \u0111\u1ed9t ph\u00e1 th\u1ef1c s\u1ef1, cho ph\u00e9p gi\u1ea3i ph\u00f3ng thu\u1ed1c k\u00e9o d\u00e0i v\u1edbi \u00edt m\u0169i ti\u00eam h\u01a1n.<\/p> <p>C\u00f4ng ty hi\u1ec7n chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng ng\u00e0y c\u00e0ng t\u0103ng cho c\u00e1c r\u1ed1i lo\u1ea1n hormone t\u0103ng tr\u01b0\u1edfng v\u00e0 \u0111i\u1ec1u tr\u1ecb h\u1ea1 canxi m\u00e1u do suy tuy\u1ebfn c\u1eadn gi\u00e1p. V\u1edbi h\u01a1n 3.100 \u0111\u01a1n thu\u1ed1c YORVIPATH t\u00ednh \u0111\u1ebfn gi\u1eefa n\u0103m 2025 v\u00e0 SKYTROFA m\u1edf r\u1ed9ng sang th\u1ecb tr\u01b0\u1eddng ng\u01b0\u1eddi l\u1edbn, \u0111\u1ed9ng c\u01a1 th\u01b0\u01a1ng m\u1ea1i \u0111ang ho\u1ea1t \u0111\u1ed9ng h\u1ebft c\u00f4ng su\u1ea5t.<\/p> <p><strong>S\u1ef1 Th\u1eadt Vui N\u0103m 2025<\/strong>: Tr\u1ee5 s\u1edf ch\u00ednh c\u1ee7a Ascendis Pharma t\u1ea1i Copenhagen c\u00f3 m\u1ed9t \"khu v\u01b0\u1eddn \u0111i\u00eau kh\u1eafc ph\u00e2n t\u1eed\" n\u01a1i nh\u00e2n vi\u00ean c\u00f3 th\u1ec3 \u0111i b\u1ed9 gi\u1eefa c\u00e1c m\u00f4 h\u00ecnh kh\u1ed5ng l\u1ed3 c\u1ee7a c\u00e1c h\u1ee3p ch\u1ea5t TransCon. C\u00e1c nh\u00e0 khoa h\u1ecdc th\u1ef1c s\u1ef1 \u0111i d\u1ea1o qua c\u00e1c s\u00e1ng t\u1ea1o c\u1ee7a h\u1ecd trong gi\u1edd ngh\u1ec9 tr\u01b0a!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Ascendis Pharma: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Ascendis Pharma A\/S (ASND) giao d\u1ecbch \u1edf m\u1ee9c <strong>194,30 USD<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>13 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi c\u00f4ng ty c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. Nh\u01b0ng b\u01b0\u1edbc ngo\u1eb7t th\u1ef1c s\u1ef1 \u0111\u1ebfn ngay tr\u01b0\u1edbc \u0111\u00f3&#8230;<\/p>\n<p><strong>30 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y FDA PDUFA cho ph\u00ea duy\u1ec7t TransCon CNP. Quy\u1ebft \u0111\u1ecbnh duy nh\u1ea5t n\u00e0y c\u00f3 th\u1ec3 l\u00e0m thay \u0111\u1ed5i ho\u00e0n to\u00e0n qu\u1ef9 \u0111\u1ea1o c\u1ed5 phi\u1ebfu trong n\u0103m t\u1edbi. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA v\u1ec1 s\u1ea3n ph\u1ea9m Ascendis \u0111\u00e3 t\u1ea1o ra nh\u1eefng bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn.<\/p>\n<h3>C\u00e1ch C\u00e1c Quy\u1ebft \u0110\u1ecbnh FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu ASND<\/h3>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Th\u00e1ng 8\/2024<\/td>\n<td>Ph\u00ea duy\u1ec7t YORVIPATH<\/td>\n<td>145 USD<\/td>\n<td>+28% (1 tu\u1ea7n)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 3\/2025<\/td>\n<td>M\u1edf r\u1ed9ng SKYTROFA<\/td>\n<td>168 USD<\/td>\n<td>+15% (3 ng\u00e0y)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 1\/2025<\/td>\n<td>K\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td>\n<td>132 USD<\/td>\n<td>-12% (d\u1eef li\u1ec7u g\u00e2y th\u1ea5t v\u1ecdng)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>M\u1eabu h\u00ecnh r\u00f5 r\u00e0ng: tin t\u00edch c\u1ef1c t\u1eeb c\u01a1 quan qu\u1ea3n l\u00fd th\u00fac \u0111\u1ea9y t\u0103ng tr\u01b0\u1edfng hai ch\u1eef s\u1ed1, trong khi th\u1ea5t b\u1ea1i g\u00e2y ra \u0111i\u1ec1u ch\u1ec9nh \u0111\u00e1ng k\u1ec3. Quy\u1ebft \u0111\u1ecbnh th\u00e1ng 11 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn nh\u1ea5t c\u1ee7a n\u0103m 2025.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 n\u0103m 2025)<\/h3>\n<p>C\u1ed5 phi\u1ebfu ASND \u0111\u00e3 t\u0103ng \u1ea5n t\u01b0\u1ee3ng <strong>75%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2<\/strong>: 111,09 USD (\u0111\u00e1y 52 tu\u1ea7n, th\u1ecb tr\u01b0\u1eddng kh\u00f4ng ch\u1eafc ch\u1eafn)<\/li>\n<li><strong>Th\u00e1ng 4<\/strong>: 150,12 USD (v\u01b0\u1ee3t qua trung b\u00ecnh \u0111\u1ed9ng 200 ng\u00e0y)<\/li>\n<li><strong>Th\u00e1ng 6<\/strong>: 188,79 USD (ti\u1ebfn g\u1ea7n m\u1ee9c cao k\u1ef7 l\u1ee5c)<\/li>\n<li><strong>Th\u00e1ng 8<\/strong>: 194,30 USD (\u0111i\u1ec1u ch\u1ec9nh g\u1ea7n m\u1ee9c \u0111\u1ec9nh)<\/li>\n<\/ul>\n<p>T\u1ea1i sao t\u0103ng m\u1ea1nh nh\u01b0 v\u1eady? Ba t\u1eeb: <strong>t\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5<\/strong>. K\u1ebft qu\u1ea3 qu\u00fd 2 n\u0103m 2025 c\u1ee7a c\u00f4ng ty cho th\u1ea5y doanh thu t\u0103ng v\u1ecdt <strong>339%<\/strong> l\u00ean 158 tri\u1ec7u euro, nh\u1edd c\u00e1c s\u1ea3n ph\u1ea9m YORVIPATH v\u00e0 SKYTROFA ra m\u1eaft th\u00e0nh c\u00f4ng.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<ul>\n<li><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: 220-240 USD (ch\u1edd ph\u00ea duy\u1ec7t FDA) \u2192 <strong>MUA M\u1ea0NH<\/strong> n\u1ebfu \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li>\n<li><strong>2026<\/strong>: 260-300 USD (th\u01b0\u01a1ng m\u1ea1i h\u00f3a \u0111\u1ea7y \u0111\u1ee7 TransCon CNP)<\/li>\n<li><strong>2028<\/strong>: 380-450 USD (m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 t\u0103ng tr\u01b0\u1edfng qu\u1ed1c t\u1ebf)<\/li>\n<li><strong>2030<\/strong>: 550-650 USD (d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng b\u1ec7nh n\u1ed9i ti\u1ebft hi\u1ebfm g\u1eb7p)<\/li>\n<\/ul>\n<p>K\u1ebft lu\u1eadn? \u0110\u00e2y l\u00e0 c\u01a1 h\u1ed9i <strong>r\u1ee7i ro cao, l\u1ee3i nhu\u1eadn cao<\/strong> ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu \u0111\u01b0\u1ee3c bi\u1ebfn \u0111\u1ed9ng ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. Quy\u1ebft \u0111\u1ecbnh FDA th\u00e1ng 11 l\u00e0 t\u1ea5t c\u1ea3\u2014ph\u00ea duy\u1ec7t c\u00f3 th\u1ec3 \u0111\u01b0a c\u1ed5 phi\u1ebfu n\u00e0y l\u00ean t\u1ea7m cao m\u1edbi.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>R\u1ee7i ro b\u1ecb FDA t\u1eeb ch\u1ed1i<\/strong>: gi\u1ea3m 20-30% n\u1ebfu TransCon CNP kh\u00f4ng \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li>\n<li><strong>Thua l\u1ed7 t\u00e0i ch\u00ednh<\/strong>: l\u1ed7 r\u00f2ng 38,9 tri\u1ec7u euro m\u1eb7c d\u00f9 doanh thu t\u0103ng m\u1ea1nh<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng cao<\/strong>: bi\u1ebfn \u0111\u1ed9ng h\u00e0ng n\u0103m 40,1% g\u00e2y dao \u0111\u1ed9ng gi\u00e1 m\u1ea1nh<\/li>\n<li><strong>\u00c1p l\u1ef1c c\u1ea1nh tranh<\/strong>: Pfizer v\u00e0 Novo Nordisk \u0111ang nh\u1eafm v\u00e0o th\u1ecb tr\u01b0\u1eddng c\u1ee7a h\u1ecd<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Doanh thu b\u00f9ng n\u1ed5<\/strong>: t\u0103ng tr\u01b0\u1edfng 339% kh\u00f4ng ph\u1ea3i nh\u1ea7m l\u1eabn\u2014\u0111\u00f3 l\u00e0 th\u1ef1c t\u1ebf<\/li>\n<li><strong>M\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/strong>: YORVIPATH hi\u1ec7n c\u00f3 m\u1eb7t t\u1ea1i h\u01a1n 75 qu\u1ed1c gia tr\u00ean to\u00e0n c\u1ea7u<\/li>\n<li><strong>D\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t<\/strong>: 494 tri\u1ec7u euro cho ho\u1ea1t \u0111\u1ed9ng<\/li>\n<li><strong>\u0110\u00e1nh gi\u00e1 c\u1ee7a chuy\u00ean gia<\/strong>: 16 tr\u00ean 16 nh\u00e0 ph\u00e2n t\u00edch \u0111\u00e1nh gi\u00e1 Mua ho\u1eb7c Mua M\u1ea1nh<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>Ch\u1edd \u0111\u1ebfn th\u00e1ng 11<\/strong>: Quy\u1ebft \u0111\u1ecbnh FDA qu\u00e1 quan tr\u1ecdng\u2014\u0111\u1eb7t v\u1ecb th\u1ebf sau tin t\u1ee9c<\/li>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 v\u1edbi t\u1ef7 l\u1ec7 2-3% danh m\u1ee5c<\/li>\n<li><strong>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7<\/strong>: t\u1ea1i 175 USD (h\u1ed7 tr\u1ee3 30 ng\u00e0y) v\u00e0 150 USD (trung b\u00ecnh \u0111\u1ed9ng 200 ng\u00e0y)<\/li>\n<li><strong>Theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/strong>: B\u00e1o c\u00e1o qu\u00fd 3 ng\u00e0y 13 th\u00e1ng 11 s\u1ebd cho th\u1ea5y ti\u1ebfn tri\u1ec3n th\u01b0\u01a1ng m\u1ea1i<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch ASND gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014r\u1ea5t \u0111\u00e1ng gi\u00e1 nh\u01b0ng d\u1ec5 c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng t\u00e2m tr\u1ea1ng m\u1ea1nh m\u1ebd. H\u00e3y chu\u1ea9n b\u1ecb s\u1ef1 \u1ed5n \u0111\u1ecbnh c\u1ea3m x\u00fac v\u00e0 d\u1ea1 d\u00e0y v\u1eefng ch\u1eafc!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Ascendis Pharma A\/S (ASND) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng c\u00f3 th\u1ec3 m\u1ea5t<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;ASND&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap tr\u00e1nh tr\u1ea3 gi\u00e1 qu\u00e1 cao khi bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Th\u1ef1c hi\u1ec7n mua<\/td>\n<td>Xem x\u00e9t ph\u00ed\u2014nh\u1eafm d\u01b0\u1edbi 1% t\u1ed5ng hoa h\u1ed3ng<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h3>\n<p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p>\n<ul>\n<li><strong>Ti\u1ec1n g\u1eedi t\u1ed1i thi\u1ec3u 5 USD<\/strong>\u2014th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi ti\u1ec1n th\u1eadt m\u00e0 kh\u00f4ng t\u1ed1n nhi\u1ec1u<\/li>\n<li><strong>X\u00e1c minh trong 1 ph\u00fat<\/strong>\u2014t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng linh ho\u1ea1t<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu l\u1ebb<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 ASND<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Ascendis Pharma N\u0103m 2025: Cu\u1ed9c C\u00e1ch M\u1ea1ng TransCon<\/h2>\n<p>Ascendis Pharma kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc b\u00ecnh th\u01b0\u1eddng\u2014h\u1ecd ti\u00ean phong cho t\u01b0\u01a1ng lai \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh n\u1ed9i ti\u1ebft hi\u1ebfm g\u1eb7p. N\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 TransCon c\u1ee7a h\u1ecd l\u00e0 m\u1ed9t b\u01b0\u1edbc \u0111\u1ed9t ph\u00e1 th\u1ef1c s\u1ef1, cho ph\u00e9p gi\u1ea3i ph\u00f3ng thu\u1ed1c k\u00e9o d\u00e0i v\u1edbi \u00edt m\u0169i ti\u00eam h\u01a1n.<\/p>\n<p>C\u00f4ng ty hi\u1ec7n chi\u1ebfm l\u0129nh th\u1ecb tr\u01b0\u1eddng ng\u00e0y c\u00e0ng t\u0103ng cho c\u00e1c r\u1ed1i lo\u1ea1n hormone t\u0103ng tr\u01b0\u1edfng v\u00e0 \u0111i\u1ec1u tr\u1ecb h\u1ea1 canxi m\u00e1u do suy tuy\u1ebfn c\u1eadn gi\u00e1p. V\u1edbi h\u01a1n 3.100 \u0111\u01a1n thu\u1ed1c YORVIPATH t\u00ednh \u0111\u1ebfn gi\u1eefa n\u0103m 2025 v\u00e0 SKYTROFA m\u1edf r\u1ed9ng sang th\u1ecb tr\u01b0\u1eddng ng\u01b0\u1eddi l\u1edbn, \u0111\u1ed9ng c\u01a1 th\u01b0\u01a1ng m\u1ea1i \u0111ang ho\u1ea1t \u0111\u1ed9ng h\u1ebft c\u00f4ng su\u1ea5t.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Vui N\u0103m 2025<\/strong>: Tr\u1ee5 s\u1edf ch\u00ednh c\u1ee7a Ascendis Pharma t\u1ea1i Copenhagen c\u00f3 m\u1ed9t &#8220;khu v\u01b0\u1eddn \u0111i\u00eau kh\u1eafc ph\u00e2n t\u1eed&#8221; n\u01a1i nh\u00e2n vi\u00ean c\u00f3 th\u1ec3 \u0111i b\u1ed9 gi\u1eefa c\u00e1c m\u00f4 h\u00ecnh kh\u1ed5ng l\u1ed3 c\u1ee7a c\u00e1c h\u1ee3p ch\u1ea5t TransCon. C\u00e1c nh\u00e0 khoa h\u1ecdc th\u1ef1c s\u1ef1 \u0111i d\u1ea1o qua c\u00e1c s\u00e1ng t\u1ea1o c\u1ee7a h\u1ecd trong gi\u1edd ngh\u1ec9 tr\u01b0a!<\/p>\n"},"faq":[{"question":"Ascendis Pharma A\/S (ASND) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Ascendis Pharma A\/S l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0110an M\u1ea1ch chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb cho c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p, s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 \u0111\u1ed9t ph\u00e1 TransCon."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu ASND?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu ASND qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, t\u00ecm m\u00e3 ch\u1ee9ng kho\u00e1n ASND, ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 th\u1ef1c hi\u1ec7n mua v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng \u0111\u1ea7u t\u01b0."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o ASND l\u00e0 g\u00ec?","answer":"R\u1ee7i ro ch\u00ednh bao g\u1ed3m kh\u1ea3 n\u0103ng FDA kh\u00f4ng ph\u00ea duy\u1ec7t TransCon CNP, thua l\u1ed7 t\u00e0i ch\u00ednh, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 \u00e1p l\u1ef1c c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty l\u1edbn nh\u01b0 Pfizer v\u00e0 Novo Nordisk."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a ASND trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu ASND c\u00f3 th\u1ec3 t\u0103ng l\u00ean 220-240 USD v\u00e0o cu\u1ed1i n\u0103m 2025 n\u1ebfu \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t, v\u00e0 ti\u1ebfp t\u1ee5c t\u0103ng \u0111\u1ebfn 550-650 USD v\u00e0o n\u0103m 2030 nh\u1edd m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 th\u1ecb tr\u01b0\u1eddng qu\u1ed1c t\u1ebf."},{"question":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean l\u00e0m g\u00ec khi \u0111\u1ea7u t\u01b0 v\u00e0o ASND?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean ch\u1edd quy\u1ebft \u0111\u1ecbnh FDA v\u00e0o th\u00e1ng 11, b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, s\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1, \u0111\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 v\u00e0 theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3 \u0111\u1ec3 \u0111\u00e1nh gi\u00e1 ti\u1ebfn tri\u1ec3n."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Ascendis Pharma A\/S (ASND) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Ascendis Pharma A\/S l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0110an M\u1ea1ch chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb cho c\u00e1c b\u1ec7nh hi\u1ebfm g\u1eb7p, s\u1eed d\u1ee5ng n\u1ec1n t\u1ea3ng c\u00f4ng ngh\u1ec7 \u0111\u1ed9t ph\u00e1 TransCon."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu ASND?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu ASND qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, t\u00ecm m\u00e3 ch\u1ee9ng kho\u00e1n ASND, ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 th\u1ef1c hi\u1ec7n mua v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng \u0111\u1ea7u t\u01b0."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o ASND l\u00e0 g\u00ec?","answer":"R\u1ee7i ro ch\u00ednh bao g\u1ed3m kh\u1ea3 n\u0103ng FDA kh\u00f4ng ph\u00ea duy\u1ec7t TransCon CNP, thua l\u1ed7 t\u00e0i ch\u00ednh, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 \u00e1p l\u1ef1c c\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty l\u1edbn nh\u01b0 Pfizer v\u00e0 Novo Nordisk."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a ASND trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu ASND c\u00f3 th\u1ec3 t\u0103ng l\u00ean 220-240 USD v\u00e0o cu\u1ed1i n\u0103m 2025 n\u1ebfu \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t, v\u00e0 ti\u1ebfp t\u1ee5c t\u0103ng \u0111\u1ebfn 550-650 USD v\u00e0o n\u0103m 2030 nh\u1edd m\u1edf r\u1ed9ng danh m\u1ee5c v\u00e0 th\u1ecb tr\u01b0\u1eddng qu\u1ed1c t\u1ebf."},{"question":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean l\u00e0m g\u00ec khi \u0111\u1ea7u t\u01b0 v\u00e0o ASND?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean ch\u1edd quy\u1ebft \u0111\u1ecbnh FDA v\u00e0o th\u00e1ng 11, b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, s\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1, \u0111\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 v\u00e0 theo d\u00f5i b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3 \u0111\u1ec3 \u0111\u00e1nh gi\u00e1 ti\u1ebfn tri\u1ec3n."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:52:21+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)\",\"datePublished\":\"2025-08-25T19:52:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\"},\"wordCount\":25,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-08-25T19:52:21+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:52:21+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)","datePublished":"2025-08-25T19:52:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"wordCount":25,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-08-25T19:52:21+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":350610,"slug":"how-to-buy-ascendis-pharma-as","post_title":"Como comprar a\u00e7\u00f5es da Ascendis Pharma A\/S (ASND) - Investimento em a\u00e7\u00f5es da Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/350609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=350609"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/350609\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=350609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=350609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=350609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}